Traitements2programmes
Essais1liés
Publications5liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Intravenous immunoglobulinSingle patient randomized double blind trial to assess whether intravenous immunoglobulin can improve the clinical outcome of a case suffering from Unverricht-Lundborg disease. Épilepsie Phase 3 À vérifier À vérifier
Intravenous immunoglobulinSingle patient randomized double blind trial to assess whether intravenous immunoglobulin can improve the clinical outcome of a case suffering from Unverricht-Lundborg disease. Épilepsie Phase 3 À vérifier À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Intravenous immunoglobulin Épilepsie Phase 3 NCT03351569 Intravenous Immunoglobulin for Unverricht-Lundborg Disease. UNKNOWN

Publications

5
MoléculeIndication / populationTitreJournalDate
Intravenous immunoglobulin Patient perspectives on hemolytic disease of the fetus and newborn and fetal and neonatal alloimmune thrombocytopenia: common experiences and insights. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Intravenous immunoglobulin Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection. Cureus
Intravenous immunoglobulin Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency. Immunotherapy
Intravenous immunoglobulin Case Report: Hereditary thrombotic thrombocytopenic purpura mimicking immune thrombocytopenia: diagnostic pitfalls of whole-exome sequencing. Frontiers in pediatrics
Intravenous immunoglobulin Integrating Cerebrospinal Fluid Metagenomic Next-Generation Sequencing and Immune Profiling in Recurrent HSV-1 Encephalitis: A Case Report and Narrative Review. Journal of child neurology